Log in to save to my catalogue

A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab a...

A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2839738622

A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance

About this item

Full title

A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Pediatric nephrology (Berlin, West), 2024-01, Vol.39 (1), p.305-308

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Membranous nephropathy is a glomerular disease characterized by the presence of immune-complexes deposited in the subepithelial space of the glomerular basement membrane. It is the main cause of nephrotic syndrome in adults, while in children it is very infrequent. Anti-CD20 monoclonal antibodies, mainly rituximab, represent a specifi...

Alternative Titles

Full title

A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2839738622

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2839738622

Other Identifiers

ISSN

0931-041X

E-ISSN

1432-198X

DOI

10.1007/s00467-023-06085-8

How to access this item